Medicare Enrolled
Dr. Peter Brian Andersson, MD
Neurology · Tarzana, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Andersson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Andersson?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Andersson
Dr. Peter Brian Andersson is a neurology specialist in Tarzana, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Andersson performed 2,111 Medicare services across 1,578 unique beneficiaries.
Between the years covered by Open Payments, Dr. Andersson received a total of $88,955 from 88 pharmaceutical and/or device companies across 1047 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Andersson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 21% volume in CA
$88,955 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,111
Medicare services
Top 21% in CA for neurology
1,578
Unique beneficiaries
$155
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
842 | $109 | $469 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
423 | $153 | $581 |
| New patient office visit, complex (60-74 min) | 198 | $183 | $998 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
175 | $415 | $2,300 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
154 | $89 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
148 | $137 | $744 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
61 | $12 | $75 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
40 | $221 | $1,750 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 37 | $239 | $500 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
33 | $255 | $2,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$88,955
Total received (2018-2024)
Avg $12,708/year across 7 years
Top 7% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,047
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$67,600 (76.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,285 (19.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,069 (4.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$9,207
2023
$17,982
2022
$24,236
2021
$22,349
2020
$12,050
2019
$1,882
2018
$1,248
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$5,731
PFIZER INC.
$334
Lilly USA, LLC
$215
MDD US Operations, LLC
$207
Teva Pharmaceuticals USA, Inc.
$200
ACADIA Pharmaceuticals Inc
$190
Neurocrine Biosciences, Inc.
$187
UCB, Inc.
$180
Otsuka America Pharmaceutical, Inc.
$178
Eisai Inc.
$167
Novartis Pharmaceuticals Corporation
$157
ARGENX US, INC.
$117
Celgene Corporation
$110
Lundbeck LLC
$100
CATALYST PHARMACEUTICALS, INC.
$99
Merz Pharmaceuticals, LLC
$97
Biogen, Inc.
$94
TG Therapeutics, Inc.
$91
Kyowa Kirin, Inc.
$89
Acorda Therapeutics, Inc
$67
Sumitomo Pharma America, Inc.
$63
SK Life Science, Inc.
$60
Azurity Pharmaceuticals, Inc.
$55
EMD Serono, Inc.
$51
Alnylam Pharmaceuticals Inc.
$51
Alexion Pharmaceuticals, Inc.
$50
Neurelis, Inc.
$31
ANI Pharmaceuticals, Inc.
$31
Genentech USA, Inc.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$28
Cadwell Industries, INC
$28
JAZZ PHARMACEUTICALS INC.
$25
Genentech, Inc.
$21
InSightec,Inc
$21
AstraZeneca Pharmaceuticals LP
$21
Axsome Therapeutics, Inc.
$18
Vanda Pharmaceuticals Inc.
$14
Top 3 companies account for 68.2% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$25,284
ABBVIE INC.
$18,399
AbbVie Inc.
$12,943
Biohaven Pharmaceuticals, Inc.
$11,781
IMPEL PHARMACEUTICALS INC.
$4,069
Teva Pharmaceuticals USA, Inc.
$1,391
Biogen, Inc.
$1,206
Novartis Pharmaceuticals Corporation
$1,177
Amgen Inc.
$846
ACADIA Pharmaceuticals Inc
$703
PFIZER INC.
$595
SK Life Science, Inc.
$566
MDD US Operations, LLC
$513
UCB, Inc.
$510
Neurocrine Biosciences, Inc.
$472
Eisai Inc.
$414
Kyowa Kirin, Inc.
$400
Alexion Pharmaceuticals, Inc.
$396
Merz Pharmaceuticals, LLC
$367
Sunovion Pharmaceuticals Inc.
$351
Amneal Pharmaceuticals LLC
$334
ARGENX US, INC.
$331
Alnylam Pharmaceuticals Inc.
$289
US WorldMeds, LLC
$281
Lundbeck LLC
$280
Sumitomo Pharma America, Inc.
$279
Genentech USA, Inc.
$263
Takeda Pharmaceuticals U.S.A., Inc.
$243
Adamas Pharmaceuticals, Inc.
$235
EMD Serono, Inc.
$211
Acorda Therapeutics, Inc
$210
Otsuka America Pharmaceutical, Inc.
$210
Biohaven Pharmaceutical Holding Company Ltd.
$204
Celgene Corporation
$173
EISAI INC.
$139
GENZYME CORPORATION
$124
ARBOR PHARMACEUTICALS, INC.
$123
CATALYST PHARMACEUTICALS, INC.
$118
Nevro Corp.
$113
HARMONY BIOSCIENCES LLC
$104
Supernus Pharmaceuticals, Inc.
$100
Azurity Pharmaceuticals, Inc.
$98
Harmony Biosciences LLC
$96
TG Therapeutics, Inc.
$91
Assertio Therapeutics, Inc.
$90
Neurelis, Inc.
$88
Octapharma USA, Inc.
$82
Upsher-Smith Laboratories LLC
$80
Banner Life Sciences, LLC
$80
Abbott Laboratories
$79
CSL Behring
$77
Merz North America, Inc.
$77
Allergan, Inc.
$72
MITSUBISHI TANABE PHARMA AMERICA, INC.
$71
Horizon Therapeutics plc
$69
JAZZ PHARMACEUTICALS INC.
$60
AstraZeneca Pharmaceuticals LP
$60
AbbVie, Inc.
$57
Axsome Therapeutics, Inc.
$55
Arbor Pharmaceuticals, Inc.
$54
Promius Pharma LLC
$49
ASSERTIO THERAPEUTICS, Inc.
$48
Bausch Health US, LLC
$44
Zyla Life Sciences, Inc.
$44
BANNER LIFE SCIENCES, LLC
$42
UPSHER-SMITH LABORATORIES LLC
$39
Janssen Pharmaceuticals, Inc
$39
Avanir Pharmaceuticals, Inc.
$34
Zyla Life Sciences
$32
ANI Pharmaceuticals, Inc.
$31
Cadwell Industries, INC
$28
Mallinckrodt LLC
$26
Impax Laboratories, Inc.
$26
MERZ NORTH AMERICA, INC.
$25
Mitsubishi Tanabe Pharma America, Inc.
$25
Catalyst Pharmaceuticals, Inc.
$24
E.R. Squibb & Sons, L.L.C.
$23
Genentech, Inc.
$21
InSightec,Inc
$21
Boston Scientific Corporation
$20
TerSera Therapeutics LLC
$20
Bayer HealthCare Pharmaceuticals Inc.
$20
LivaNova USA, Inc.
$19
Vertical Pharmaceuticals, LLC
$17
Cala Health, Inc.
$17
Vanda Pharmaceuticals Inc.
$14
Collegium Pharmaceutical, Inc.
$14
AngioDynamics, Inc.
$13
Top 3 companies account for 63.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AURYON LASER SYSTEM 100-120 VAC · AUSTEDO · AVONEX · Aimovig · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · BRIUMVI · Betaseron · Briviact · CALA TRIO · CAMBIA · COMIRNATY · COPAXONE · Cambia · DIVIGEL · DUOPA · Duopa · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · ERGOMAR · Exablate · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · GRALISE · Gocovri · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONPATTRO · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · PANZYGA · PONVORY · PURIFIED CORTROPHIN GEL · Proclaim Family of SCS IPGs · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · SOLIRIS · SPRIX · SUNOSI · Senza · Soliris · Sunosi · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · WAINUA · Wakix · XADAGO · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for neurology in CA.
Geographic Context
Neurologists within 10 mi
469
Per 100K population
4.8
County median income
$87,760
Nearest hospital
PROVIDENCE CEDARS SINAI TARZANA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Andersson is a clinical cardiology specialist, with above-average Medicare volume (top 21% in CA), with speaking/promotional industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Andersson experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Andersson performed 842 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Andersson receive payments from pharmaceutical companies?
Yes. Dr. Andersson received a total of $88,955 from 88 companies across 1,047 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Andersson's costs compare to other neurologists in Tarzana?
Dr. Andersson's average Medicare payment per service is $155. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Andersson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Tarzana
Browse neurologists in Tarzana ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in CA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in CA
Which CA neurologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology